We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-9.72%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.67B
AUM Growth
-$658M
Cap. Flow
+$79.2M
Cap. Flow %
1.19%
Top 10 Hldgs %
57.1%
Holding
295
New
64
Increased
76
Reduced
63
Closed
70

Top Buys

Rank Stock Value
1
FRPT icon
Freshpet
FRPT
+$87.7M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$59.2M
3
STAA icon
STAAR Surgical
STAA
+$42.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$35.7M
5
SNN icon
Smith & Nephew
SNN
+$34.1M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$81.1M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$79.9M
3
GSK icon
GSK
GSK
+$73.2M
4
HUM icon
Humana
HUM
+$69.2M
5
BUD icon
AB InBev
BUD
+$68M

Sector Composition

Rank Sector Weight
1 Healthcare 35.45%
2 Consumer Discretionary 6.85%
3 Consumer Staples 5.47%
4 Technology 5.39%
5 Communication Services 1.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SKX
76
DELISTED
Skechers
SKX
$16.8M 0.25%
295,340
+2,707
+0.9% +$176K
DHR icon
77
Danaher
DHR
$141B
$16.6M 0.25%
+80,992
New +$17.7M
IMVT icon
78
CALL
Immunovant
IMVT
$8.2B
$15.4M 0.23%
900,000
-450,000
-33% -$9.41M
HUM icon
79
Humana
HUM
$44.1B
$14.8M 0.22%
56,023
-255,977
-82% -$69.2M
XOM icon
80
ExxonMobil
XOM
$642B
$14.7M 0.22%
123,266
-69,190
-36% -$7.65M
GSK icon
81
GSK
GSK
$104B
$14.6M 0.22%
378,000
-2,000,000
-84% -$73.2M
EAT icon
82
Brinker International
EAT
$9.75B
$14.6M 0.22%
97,734
+47,206
+93% +$7.26M
ISRG icon
83
Intuitive Surgical
ISRG
$132B
$14.4M 0.22%
29,058
-19,982
-41% -$11.1M
NPCE icon
84
Neuropace
NPCE
$474M
$14.2M 0.21%
1,153,614
+561,000
+95% +$7.02M
DRI icon
85
Darden Restaurants
DRI
$24.1B
$12.8M 0.19%
+61,578
New +$11.9M
GMED icon
86
Globus Medical
GMED
$11B
$12.7M 0.19%
+172,823
New +$14.3M
MCD icon
87
McDonald's
MCD
$196B
$12.5M 0.19%
+40,000
New +$12M
NBIS
88
Nebius Group N.V.
NBIS
$48.2B
$12M 0.18%
568,092
+7,184
+1% +$236K
DT icon
89
Dynatrace
DT
$14.2B
$11.8M 0.18%
+250,000
New +$13.7M
NVDA icon
90
NVIDIA
NVDA
$5.3T
$11.5M 0.17%
106,110
-18,105
-15% -$2.29M
NKE icon
91
Nike
NKE
$62.3B
$11M 0.17%
+173,451
New +$12.8M
TSM icon
92
TSMC
TSM
$2.17T
$10.3M 0.15%
62,000
+12,000
+24% +$2.33M
AXGN icon
93
Axogen
AXGN
$2.38B
$9.96M 0.15%
538,278
-74,722
-12% -$1.35M
ROST icon
94
Ross Stores
ROST
$81.6B
$9.54M 0.14%
74,686
-30,004
-29% -$4.2M
DECK icon
95
Deckers Outdoor
DECK
$13.3B
$9.11M 0.14%
+81,486
New +$13.2M
APP icon
96
Applovin
APP
$113B
$8.78M 0.13%
33,138
+26,992
+439% +$9.3M
MGNX icon
97
MacroGenics
MGNX
$255M
$8M 0.12%
6,296,000
+20,000
+0.3% +$52.2K
MDB icon
98
MongoDB
MDB
$29.8B
$7.89M 0.12%
+44,965
New +$11M
YUM icon
99
Yum! Brands
YUM
$41.6B
$7.78M 0.12%
+49,452
New +$7.12M
NVO
100
Novo Nordisk
NVO
$203B
$7.5M 0.11%
108,000
-604,000
-85% -$49.9M
2 3
4
5 6

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Armistice Capital held 295 positions worth $6.67B, down 9% from $7.33B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Armistice Capital's Q1 2025 filing shows 64 new, 76 increased, 63 reduced and 70 closed positions. Its largest new stake was Freshpet: 716,960 shares worth $59.6M. The largest sale was Vertex Pharmaceuticals, an estimated $81.1M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

  • Armistice Capital's largest Q1 2025 buy was Freshpet: 716,960 shares worth $59.6M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q1 2025, an estimated $59.2M increase.
  • Armistice Capital's biggest Q1 2025 reduction was Vertex Pharmaceuticals, cutting an estimated $81.1M.
  • Armistice Capital fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $79.9M.
  • Armistice Capital's ten largest holdings make up 57% of its $6.67B portfolio in Q1 2025.
  • Armistice Capital opened 64 new positions and closed 70 in Q1 2025.
  • Armistice Capital's portfolio value fell 9% quarter-over-quarter to $6.67B.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.